author-photo

Harris S. Soifer

City of Hope National Medical Center

20

Papers

941

Citations

Citation Trend

Filter By

Papers (20) Sort By

JournalConferenceOthers

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.

2021 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (8)
Abstract 2940: Molecular tumor profiling identifies actionable targets in patients with cholangiocarcinoma

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (2)
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (25)
Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Activity of the FGFR1–3 inhibitor infigratinib in patients with upper tract urothelial carcinoma and urothelial carcinoma of the bladder: Latest efficacy findings and comprehensive genomic profiling/cell-free DNA data

2019 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (0)
940PcfDNA is an acceptable but insufficient means of characterizing FGFR3 mutation in patients with metastatic urothelial cancer (mUC)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells

2015 Nucleic Acids Research
Show All
- Source
- Cite
- Save
Citations (54)
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.

2010 Nucleic Acids Research
Show All
- Source
- Cite
- Save
Citations (284)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号